Fairvalue-Calculator Fairvalue-Calculator
EN DE

Hofseth BioCare ASA (HOFBF) Fair Value & Analysis

Consumer Defensive · US · Market cap $65.8M

Price$0.1666
Fair Value$0.2900
Upside+74.1%
Quality95/100
Evidence: Low Range $0.1900 – $0.3600

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Hofseth BioCare ASA (HOFBF) currently trades at $0.1666, while our model-based Fair Value estimate is $0.2900 — implying the stock looks roughly 74.1% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Turkey, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a fish oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are calcium collagen complexes that support joint and bone health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was founded in 2000 and is headquartered in Ålesund, Norway.

Open the full interactive analysis →

Similar stocks

Nestlé S.A (NESN) -30% Foshan Haitian Flavouring and Food Company (603288) -22% Nestlé India Limited (NESTLEIND) -74% Grupo Bimbo, S.A. (BIMBOA) -21% Uni-President Enterprises Corp (1216) -3% Britannia Industries Limited (BRITANNIA) -64%

Frequently asked questions

Is Hofseth BioCare ASA (HOFBF) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.2900 versus a price of $0.1666 — about +74% (undervalued). Model-based estimate, not financial advice.
What is the fair value of HOFBF?
Our 21-model fair value for Hofseth BioCare ASA is $0.2900 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.1666.
What is the quality score of HOFBF?
Hofseth BioCare ASA has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.